ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028

Lifesciences | Healthcare IT

ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028

Market by Product, Application, End-user, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Asia-Pacific digital genome market is expected to progress with a CAGR of 10.52% in terms of revenue throughout the estimated years between 2021 and 2028.


Report scope can be customized per your requirements. Request For Customization

The countries assessed in this market include:

•           China

•           Japan

•           India

•           Australia & New Zealand

•           South Korea

•           ASEAN countries

•           Rest of APAC countries

The Government of China is supporting the development of genomics, and with the government’s backing, players in the Chinese market are investing significantly in genetic research. For instance, the Chinese Academy of Sciences launched an initiative for the development of precision medicine in 2016. It also invested close to $9 billion in a project to sequence more than 100 million human genomes by the year 2030.

In China, genomics is booming due to the rising demand for genetic sequencing. Moreover, the country has listed genomics as a key strategic field in its 13th five-year plan. In addition, collaborations between the local and international entities are taking place for developing the genomics infrastructure. All these factors are together helping the Chinese market for digital genome to flourish in the coming years.

Japan is working on strengthening its healthcare system to support the betterment of its public. The government of the nation is focusing on the development of genomics, and for this, it has initiated various programs and institutes in the country. For instance, the Japan Agency for Medical Research and Development is promoting research in the field of genomic medicine and also for creating next-generation precision medicine through several programs. These factors are accelerating the progress of the Japanese digital genome market.

Illumina Inc develops, manufactures, and distributes products and solutions for multiple life sciences methods and procedures. Life sciences and clinical genomics are the principal markets in which the company operates. Illumina offers an extensive range of products to help in applications like drug development, advanced disease research, and molecular test development. The company also offers services such as genotyping, whole-genome sequencing, and microarray projects. The company distributes its products directly to customers in the Asia-Pacific.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. ASIA-PACIFIC DIGITAL GENOME MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1. THREAT OF NEW ENTRANTS

2.1.2. THREAT OF SUBSTITUTE PRODUCTS

2.1.3. BARGAINING POWER OF BUYERS

2.1.4. BARGAINING POWER OF SUPPLIERS

2.1.5. COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET

2.3. MARKET ATTRACTIVENESS INDEX

2.4. VENDOR LANDSCAPE

2.5. KEY INSIGHTS

2.6. KEY DRIVERS

2.6.1. PROLIFERATING BURDEN OF CHRONIC DISEASES

2.6.2. CONTINUOUS FUNDING BY THE MANUFACTURERS AND GOVERNMENT IN THE FIELD OF GENOMICS

2.7. KEY RESTRAINTS

2.7.1. SECURITY RISKS ASSOCIATED WITH DIGITAL GENOME

2.7.2. LACK OF SKILLED PROFESSIONALS IN THE FIELD OF GENOME TECHNOLOGY

2.8. KEY OPPORTUNITIES

2.8.1. TECHNOLOGICAL ADVANCEMENTS

2.8.2. PREVAILING AWARENESS IN THE DEVELOPING ECONOMIES REGARDING DNA SEQUENCING TECHNOLOGIES

3. DIGITAL GENOME MARKET OUTLOOK - BY PRODUCT

3.1. SEQUENCING AND ANALYZER INSTRUMENTS

3.2. DNA/RNA ANALYSIS

3.3. SEQUENCING AND ANALYSIS SOFTWARE

3.4. SEQUENCING CHIPS

3.5. SAMPLE PREP INSTRUMENTS

4. DIGITAL GENOME MARKET OUTLOOK - BY APPLICATION

4.1. DIAGNOSTICS

4.2. DRUG DISCOVERY

4.3. ACADEMIC RESEARCH

4.4. PERSONALIZED MEDICINE

4.5. AGRICULTURAL

4.6. OTHER APPLICATIONS

5. DIGITAL GENOME MARKET OUTLOOK - BY END-USER

5.1. DIAGNOSTICS AND FORENSIC LABS

5.2. ACADEMIC RESEARCH INSTITUTES

5.3. HOSPITALS

5.4. OTHER END-USERS

6. DIGITAL GENOME MARKET - ASIA-PACIFIC

6.1. COUNTRY ANALYSIS

6.1.1. CHINA

6.1.2. JAPAN

6.1.3. AUSTRALIA & NEW ZEALAND

6.1.4. INDIA

6.1.5. SOUTH KOREA

6.1.6. ASEAN COUNTRIES

6.1.7. REST OF ASIA-PACIFIC

7. COMPANY PROFILE

7.1. QIAGEN NV

7.2. OXFORD NANOPORE TECHNOLOGIES LTD

7.3. BECTON, DICKINSON, AND COMPANY (BD)

7.4. ILLUMINA INC

7.5. THERMO FISHER SCIENTIFIC INC

7.6. PACIFIC BIOSCIENCE

7.7. BIO-RAD LABORATORIES INC

7.8. F. HOFFMANN-LA ROCHE

7.9. PERKINELMER INC

7.10. REGENERON PHARMACEUTICALS

7.11. BIOMERIEUX SA

7.12. ABBOTT LABORATORIES

7.13. AGILENT TECHNOLOGIES INC.

7.14. INSCRIPTA

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1. OBJECTIVES OF STUDY

8.1.2. SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1. PRIMARY DATA SOURCES

8.2.2. SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1. EVALUATION OF PROPOSED MARKET

8.3.2. IDENTIFICATION OF DATA SOURCES

8.3.3. ASSESSMENT OF MARKET DETERMINANTS

8.3.4. DATA COLLECTION

8.3.5. DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       ASIA-PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR LANDSCAPE

TABLE 3:       ASIA-PACIFIC DIGITAL GENOME MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 4:       ASIA-PACIFIC DIGITAL GENOME MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 5:       ASIA-PACIFIC DIGITAL GENOME MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 6:       ASIA-PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     ASIA-PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 3:     ASIA-PACIFIC DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)

FIGURE 4:     ASIA-PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 5:     ASIA-PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)

FIGURE 6:     ASIA-PACIFIC DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7:     ASIA-PACIFIC DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 8:     ASIA-PACIFIC DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 9:     ASIA-PACIFIC DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 10:  ASIA-PACIFIC DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 11:  ASIA-PACIFIC DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION)

FIGURE 12:  ASIA-PACIFIC DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 13:  ASIA-PACIFIC DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)

FIGURE 14:  ASIA-PACIFIC DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 15:  ASIA-PACIFIC DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 16:  ASIA-PACIFIC DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 17:  ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 18:  CHINA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 19:  JAPAN DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 20:  AUSTRALIA & NEW ZEALAND DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 21:  INDIA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 22:  SOUTH KOREA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  ASEAN COUNTRIES DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

FIGURE 24:  REST OF ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;